Click here for more information
DeFronzo, MD Professor of Medicine Chief of the Diabetes Division University of Texas Health Science Center at San Antonio Disclosures: DeFronzo reports serving on an advisory board for Aardvark, Alnylam, AstraZeneca, Boehringer Ingelheim, Corcept, Intarcia, Novo Nordisk and Renalytix
If youre considering medical weight loss, consult an experienced endocrinologist Dr Moxit Shah to determine whether GLP-1 therapy is right for you.
You have changed my life
In addition to taking Ozempic or Mounjaro, a healthy diet and an increased amount of physical activity can go a long way to improving your heart health
Even my surgeon asked how I achieved this transformation and I told him, without hesitation, MDWatch. My new goal is 120125 lbs, and I know Ill get there with the continued support of the MDWatch team